ISRCTN68095597
Completed
Not Applicable
A randomised controlled trial using MRI scans and cognitive testing to determine the effect of meditation on brain structure and cognition
Aarhus University (Denmark)0 sites60 target enrollmentMay 19, 2011
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Meditation practice
- Sponsor
- Aarhus University (Denmark)
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Either sex, aged 18\-40 years, ethnic Danes
- •2\. Right handed
- •3\. Health subjects with no history of neurological disorders, psychological and/or psychiatric, cardiovascular or respiratory diseases, brain injury, cancer, addiction to drugs/alcohol, severe impediment to limb movement, hearing and vision
- •4\. Normal MRI brain scan
Exclusion Criteria
- •1\. Frequent diving, high altitude climbing or flying or other activities related to the respiratory system
- •2\. Recent biofeedback training, hypnosis and acupuncture (due to the possible modulating of the vagal output)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Approaches to long-term active surveillance of patients with prostate cancer (IP9 – ATLAS)Prostate cancerCancerISRCTN11447662Imperial College London1,263
Completed
Not Applicable
A clinical and imaging trial to study which one is more effective in between platelet rich plasma injection in comparison to Extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis.CTRI/2021/04/033178AIIMS PATNA72
Recruiting
Not Applicable
A randomised controlled trial of fMRI-neurofeedback in depressioAffective DisorderDepression10027946NL-OMON54250niversiteit Maastricht120
Completed
Not Applicable
MRI Scan of patients implanted with MRI conditional Cardiac Rhythm Management systemHealth Condition 1: null- patients indicated for any one of the following: ICD / CRT-D / PacemakerCTRI/2017/05/008447St Jude Medical India Ltd30
Completed
Phase 4
A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDsRheumatoid ArthritisNCT01034397Hoffmann-La Roche54